Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Analyst Ratings Changes
A number of research analysts have recently commented on ACHC shares. BMO Capital Markets upped their price target on Acadia Healthcare from $67.00 to $82.00 in a research report on Friday, May 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Acadia Healthcare from $70.00 to $82.00 in a research note on Monday, August 1st. UBS Group raised their price objective on shares of Acadia Healthcare from $82.00 to $90.00 and gave the stock a "buy" rating in a report on Thursday, July 28th. Mizuho lifted their price objective on shares of Acadia Healthcare from $64.00 to $69.00 in a research note on Wednesday, May 4th. Finally, Jefferies Financial Group increased their target price on Acadia Healthcare from $85.00 to $95.00 in a research report on Thursday, July 28th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $81.89.
Acadia Healthcare Price Performance
Shares of ACHC Stock traded up $0.52 on Thursday, reaching $82.01. The company's stock had a trading volume of 2,943 shares, compared to its average volume of 609,600. The company has a market capitalization of $7.45 billion, a P/E ratio of 26.72, a PEG ratio of 1.96 and a beta of 1.30. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.52. The stock's 50 day simple moving average is $74.48 and its 200-day simple moving average is $68.39. Acadia Healthcare has a 12-month low of $50.07 and a 12-month high of $83.63.
Acadia Healthcare (NASDAQ:ACHC - Get Rating) last posted its quarterly earnings data on Wednesday, July 27th. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.07. Acadia Healthcare had a net margin of 11.32% and a return on equity of 10.34%. The company had revenue of $651.72 million for the quarter, compared to analysts' expectations of $650.80 million. During the same period in the prior year, the business earned $0.71 earnings per share. Acadia Healthcare's revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, equities analysts predict that Acadia Healthcare will post 3.09 earnings per share for the current fiscal year.
Insider Transactions at Acadia Healthcare
In other Acadia Healthcare news, EVP Christopher L. Howard sold 12,214 shares of the firm's stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $81.67, for a total transaction of $997,517.38. Following the sale, the executive vice president now owns 149,147 shares in the company, valued at $12,180,835.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director William M. Petrie sold 6,000 shares of the company's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $83.42, for a total value of $500,520.00. Following the completion of the sale, the director now owns 31,769 shares of the company's stock, valued at approximately $2,650,169.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Christopher L. Howard sold 12,214 shares of Acadia Healthcare stock in a transaction on Monday, August 8th. The stock was sold at an average price of $81.67, for a total transaction of $997,517.38. Following the completion of the transaction, the executive vice president now owns 149,147 shares in the company, valued at approximately $12,180,835.49. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,094 shares of company stock valued at $2,375,868. Insiders own 1.90% of the company's stock.
